Screener
Integra LifeSciences IART Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 2,520,113 | 2,558,538 |
| Stockholders’ equity: | ||
| Preferred stock; no par value; 15,000 authorized shares; none outstanding | — | — |
| Common stock; $0.01 par value; 240,000 authorized shares; 92,130 and 92,286 issued at June 30, 2026 and December 31, 2025, respectively | 921 | 923 |
| Additional paid-in capital | 1,346,265 | 1,338,386 |
| Treasury stock, at cost; 14,351 shares and 14,399 shares at June 30, 2026 and December 31, 2025, respectively | (686,918) | (689,210) |
| Accumulated other comprehensive loss | (40,197) | (30,077) |
| Retained earnings | 423,306 | 423,441 |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's common stock?
- Integra LifeSciences (IART) reported common stock of 240M in Q2 2026.
- How has Integra LifeSciences's common stock changed year-over-year?
- Integra LifeSciences's common stock decreased by 0.0% year-over-year, from 240M to 240M.
- What is the long-term trend for Integra LifeSciences's common stock?
- Over 5 years (2020 to 2025), Integra LifeSciences's common stock has grown at a 0.7% compound annual growth rate (CAGR), from 893K to 923K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Integra LifeSciences's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude